$65.9M in CY2024 Part D spend4.9M claims · 1.6M beneficiaries · 329 plans surveyed
Questions a plan sponsor actually asks.
What is Pioglitazone used for?
Pioglitazone is a Peroxisome Proliferator Receptor alpha Agonist medication tracked in Medicare Part D.
Is there a generic for Pioglitazone?
Yes. 33 ANDAs filed at FDA, 11 generic manufacturers currently shipping.
How much does my plan pay for Pioglitazone?
Across 329 Part D plans, Pioglitazone averages $0.069/unit (NADAC). Lowest available: $0.069/unit. Highest in distribution: $0.069/unit.
Is Pioglitazone on the FDA shortage list?
No. Pioglitazone is not currently on the FDA Drug Shortage Database.
7 additional drug-specific questions are indexed in the page's FAQPage schema for search engines and LLM crawlers, beyond what renders visually above. View page source for the complete JSON-LD.
Same class. Different math.
Sources · every number above traces back.
Drug identity, dosage forms, brand names: openFDA NDC Directory · First approval, ANDA history: FDA Orange Book (10 approvals on file) · NADAC unit costs: CMS NADAC weekly file (20 NDCs benchmarked) · Formulary tier and PA placement: CMS Part D Formulary file (329 plans) · Annualized spend, claims, beneficiaries: CMS Part D Spending Dashboard (CY2024) · Shortage status: FDA Drug Shortage Database · 340B exposure: HRSA OPAIS. Methodology and reproducibility notes on /methodology.